SOURCES:

Colleen Krejewski, MD, assistant professor of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh.

Sheila Chhutani, MD, OB-GYN, Texas Health Presbyterian Hospital Dallas.

Richard Kaye, MD, OB-GYN, Texas Health Presbyterian Hospital Plano.

American Congress of Obstetricians and Gynecologists, Committee Opinion: “Risk of Venous Thromboembolism Among Users of Drospirenone-Containing Oral Contraceptive Pills.”

Centers for Disease Control: Summary Chart of U.S. Medical Eligibility Criteria for Contraceptive Use.

FamilyDoctor.org: Progestin-Only Contraceptives.

National Cancer Institute: Oral Contraception and Cancer Risk.

Marchbanks, PA, Contraception, April 2012.

Bedsider.org: “What’s the Risk?”

FDA.gov: Depo-Provera Contraceptive injection (medroxyprogesterone acetate) injectable suspension

Berenson, A, American Journal of Obstetrics & Gynecology, March, 2009

American Congress of Obstetricians and Gynecologists, Committee Opinion: “Depot Medroxyprogesterone Acetate and Bone Effects”

Planned Parenthood: “IUD,” “When does an IUD start working?”

Association of Reproductive Health Professionals: “Health Matters Fact Sheets: Copper T IUD,” “Non-hormonal Contraceptive Methods,” “Methods Match.”

Source: https://www.webmd.com/sex/birth-control/features/is-your-birth-control-as-safe-as-you-think?src=RSS_PUBLIC